Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Department of Medicine, University of Maryland Medical Center, Baltimore, Maryland, USA.
Clin Infect Dis. 2021 Sep 15;73(6):1103-1106. doi: 10.1093/cid/ciab262.
Three rapid diagnostic test panels (Verigene BC-GN, BioFire BCID, and BCID 2 [RUO]) were compared using the Desirability of Outcome Ranking Management of Antimicrobial Therapy (DOOR-MAT) to evaluate potential downstream antimicrobial prescribing decisions resulting from the panels' different organism and resistance detection. BioFire BCID 2 (RUO) had the best mean DOOR-MAT scores.
三种快速诊断测试试剂盒(Verigene BC-GN、BioFire BCID 和 BCID 2[RUO])通过 Desirability of Outcome Ranking Management of Antimicrobial Therapy(DOOR-MAT)进行比较,以评估这些试剂盒不同的病原体和耐药性检测结果对下游抗菌药物处方决策的潜在影响。BioFire BCID 2(RUO)的平均 DOOR-MAT 评分最高。